Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
586
datasets available to search
ShareScore release 0.9.0
Dataset results
586 results for “allogeneic stem cell transplant”
Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT02759731. IPD Sharing: YES. Countries: 1. Publications: 0.
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
ClinicalTrials.gov study NCT03513328. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT03964922. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
ClinicalTrials.gov study NCT01982682. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)
ClinicalTrials.gov study NCT02169505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)
ClinicalTrials.gov study NCT01757197. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency
ClinicalTrials.gov study NCT05907746. IPD Sharing: YES. Countries: 1. Publications: 0.
Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT02136797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non-Myeloablative Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00525876. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01471444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplant for CLL
ClinicalTrials.gov study NCT01629511. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT01646645. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT07013370. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients
ClinicalTrials.gov study NCT03295058. IPD Sharing: Not stated. Countries: 0. Publications: 7.
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
ClinicalTrials.gov study NCT00578903. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00781170. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies
ClinicalTrials.gov study NCT00536978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT00683046. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT00143845. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)
ClinicalTrials.gov study NCT01139164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.